Places
Home
Graphs
Prefixes
Admin
Users
Settings
Plugins
Statistics
Repository
Load local file
Load from HTTP
Load from library
Remove triples
Clear repository
Query
YASGUI SPARQL Editor
Simple Form
SWISH Prolog shell
Help
Documentation
Tutorial
Roadmap
HTTP Services
Login
Distinct subjects for predicate
<http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PrecipitantDrugOfInteraction>
sorted by frequency
Resource
Count
amiodarone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
amiodarone is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
1
amiodarone is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
amiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
amiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
1
amiodarone is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
amiodarone is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
amiodarone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
aripiprazole increases the AUC of escitalopram
1
aripiprazole increases the AUC of venlafaxine
1
atazanavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
atazanavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
atazanavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
atazanavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
atorvastatin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
atorvastatin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
bupropion increases the AUC of desipramine
1
bupropion is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
bupropion is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
cimetidine increases the AUC of amitriptyline
1
cimetidine increases the AUC of citalopram
1
cimetidine increases the AUC of doxepin
1
cimetidine increases the AUC of erythrohydrobupropion
1
cimetidine increases the AUC of escitalopram
1
cimetidine increases the AUC of imipramine
1
cimetidine increases the AUC of mirtazapine
1
cimetidine increases the AUC of paroxetine
1
cimetidine increases the AUC of quetiapine
1
cimetidine increases the AUC of sertraline
1
cimetidine increases the AUC of theophylline
1
cimetidine increases the AUC of threohydrobupropion
1
cimetidine increases the AUC of venlafaxine
1
cimetidine increases the AUC of ziprasidone
1
cimetidine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
cimetidine is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
cimetidine is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
cimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
cimetidine is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
cimetidine is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
cimetidine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
cinacalcet is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
cinacalcet is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
ciprofloxacin is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
ciprofloxacin is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
ciprofloxacin is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
citalopram increases the AUC of desipramine
1
clarithromycin increases the AUC of atorvastatin
1
clarithromycin increases the AUC of lansoprazole
1
clarithromycin increases the AUC of midazolam
1
clarithromycin increases the AUC of pravastatin
1
clarithromycin increases the AUC of trazodone
1
clarithromycin increases the AUC of triazolam
1
clarithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
clarithromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
clarithromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
clarithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
clopidogrel increases the AUC of bupropion
1
desvenlafaxine increases the AUC of desipramine
1
diltiazem increases the AUC of beta-hydroxy-lovastatin
1
diltiazem increases the AUC of imipramine
1
diltiazem increases the AUC of midazolam
1
diltiazem increases the AUC of simvastatin
1
diltiazem increases the AUC of triazolam
1
diltiazem is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
diltiazem is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
diphenhydramine increases the AUC of venlafaxine
1
duloxetine increases the AUC of theophylline
1
duloxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
duloxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
erythromycin increases the AUC of alprazolam
1
erythromycin increases the AUC of atorvastatin
1
erythromycin increases the AUC of beta-hydroxy-simvastatin
1
erythromycin increases the AUC of midazolam
1
erythromycin increases the AUC of quetiapine
1
erythromycin increases the AUC of simvastatin
1
erythromycin increases the AUC of triazolam
1
erythromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
erythromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
fluconazole increases the AUC of fluvastatin
1
fluconazole increases the AUC of midazolam
1
fluconazole increases the AUC of triazolam
1
fluconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
fluconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
1
fluconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
fluconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
1
fluconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
fluconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
fluoxetine increases the AUC of alprazolam
1
fluoxetine increases the AUC of desipramine
1
fluoxetine increases the AUC of imipramine
1
fluoxetine increases the AUC of olanzapine
1
fluoxetine increases the AUC of propafenone
1
fluoxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
fluoxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
fluvoxamine increases the AUC of clozapine
1
fluvoxamine increases the AUC of duloxetine
1
fluvoxamine increases the AUC of lansoprazole
1
fluvoxamine increases the AUC of mexiletine
1
fluvoxamine increases the AUC of omeprazole
1
fluvoxamine increases the AUC of quinidine
1
fluvoxamine increases the AUC of theophylline
1
fluvoxamine increases the AUC of thioridazine
1
fluvoxamine increases the AUC of tolbutamide
1
fluvoxamine is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
1
fluvoxamine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
fluvoxamine is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
1
fluvoxamine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
fluvoxamine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
fluvoxamine is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
1
fluvoxamine is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
1
gemfibrozil is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C8
1
iloperidone is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
iloperidone is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
indinavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
indinavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
indinavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
indinavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
itraconazole increases the AUC of 3alpha-hydroxypravastatin
1
itraconazole increases the AUC of alprazolam
1
itraconazole increases the AUC of atorvastatin
1
itraconazole increases the AUC of beta-hydroxy-lovastatin
1
itraconazole increases the AUC of lovastatin
1
itraconazole increases the AUC of midazolam
1
itraconazole increases the AUC of pravastatin
1
itraconazole increases the AUC of rosuvastatin
1
itraconazole increases the AUC of triazolam
1
itraconazole increases the AUC of zolpidem
1
itraconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
itraconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
ketoconazole increases the AUC of O-desmethylvenlafaxine
1
ketoconazole increases the AUC of alprazolam
1
ketoconazole increases the AUC of amitriptyline
1
ketoconazole increases the AUC of desvenlafaxine
1
ketoconazole increases the AUC of imipramine
1
ketoconazole increases the AUC of midazolam
1
ketoconazole increases the AUC of simvastatin
1
ketoconazole increases the AUC of triazolam
1
ketoconazole increases the AUC of venlafaxine
1
ketoconazole increases the AUC of zolpidem
1
ketoconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
ketoconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
lansoprazole increases the AUC of lansoprazole
1
mexiletine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
mexiletine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
mexiletine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
modafinil is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
1
modafinil is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
1
modafinil-sulfone is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
1
modafinil-sulfone is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
1
nefazodone increases the AUC of alprazolam
1
nefazodone increases the AUC of midazolam
1
nefazodone increases the AUC of triazolam
1
nefazodone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
nefazodone is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
nefazodone is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
nefazodone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
norfloxacin is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
norfloxacin is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
norfloxacin is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
omeprazole increases the AUC of escitalopram
1
omeprazole is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
1
omeprazole is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
1
paroxetine increases the AUC of desipramine
1
paroxetine increases the AUC of duloxetine
1
paroxetine increases the AUC of imipramine
1
paroxetine increases the AUC of mirtazapine
1
paroxetine increases the AUC of nortriptyline
1
paroxetine increases the AUC of paliperidone
1
paroxetine increases the AUC of risperidone
1
paroxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
paroxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
prasugrel increases the AUC of bupropion
1
propafenone is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
propafenone is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
propafenone is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
quinidine increases the AUC of venlafaxine
1
quinidine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
quinidine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
ranolazine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
ranolazine is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
ranolazine is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
ranolazine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
ritonavir increases the AUC of trazodone
1
ritonavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
ritonavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
ritonavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
ritonavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
ritonavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
sertraline increases the AUC of desipramine
1
sertraline is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
sertraline is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
telithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
telithromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
telithromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
telithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
terbinafine increases the AUC of paroxetine
1
terbinafine increases the AUC of venlafaxine
1
terbinafine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
terbinafine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
1
teriflunomide is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
1
teriflunomide is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
1
ticlopidine increases the AUC of bupropion
1
trimethoprim is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C8
1
valproate increases the AUC of hydroxybupropion
1
venlafaxine increases the AUC of desipramine
1
venlafaxine increases the AUC of haloperidol
1
venlafaxine increases the AUC of imipramine
1
venlafaxine increases the AUC of risperidone
1
venlafaxine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
1
venlafaxine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
1
verapamil increases the AUC of imipramine
1
verapamil increases the AUC of risperidone
1
verapamil is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
1
verapamil is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
1
verapamil is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
1
verapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
1
verapamil is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
1
verapamil is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
verapamil is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
1
voriconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
1
voriconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
1
voriconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
1
voriconazole is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
1
voriconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
voriconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
1
voriconazole-n-oxide is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
1
voriconazole-n-oxide is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
1
voriconazole-n-oxide is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
1
voriconazole-n-oxide is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
voriconazole-n-oxide is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
1
zafirlukast is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of iloperidone by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
1
zafirlukast is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
1
zafirlukast is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
1